Severe Asthma, Home Spirometry, Activity Tracker, Benralizumab
Showing 1 - 25 of >10,000
Impact of Eosinophil Depletion on T2 Inflammation. (BEUTI)
Not yet recruiting
- Asthma
-
London, United KingdomGuy's & St Thomas' NHS Foundation Trust
Apr 26, 2023
Fluctuation Analyses of Asthma Patients With Biologics Use
Not yet recruiting
- Asthma
- Biological Drug
- (no location specified)
Sep 7, 2023
Benralizumab in Real-World Use in Severe Eosinophilic Asthma
Recruiting
- Asthma
-
Changhua City, Taiwan
- +7 more
Feb 16, 2023
Asthma Trial in Germany
Active, not recruiting
- Asthma
-
Aschaffenburg, Germany
- +51 more
Nov 3, 2022
Adults With Severe Eosinophilic Asthma on Benralizumab.
Active, not recruiting
- Severe Eosinophilic Asthma
- Survey Administration
-
Calgary, Alberta, Canada
- +19 more
Dec 1, 2022
Asthma Trial in Rotterdam (Budesonide/Formoterol fumarate dihydrate)
Recruiting
- Asthma
- Budesonide/Formoterol fumarate dihydrate
-
Rotterdam, Zuid-Holland, NetherlandsFranciscus Gasthuis & Vlietland
Apr 14, 2023
Real-world Use of Benralizumab in Severe Eosinophilic Asthma in
Active, not recruiting
- Severe Asthma
-
Bruxelles, Belgium
- +9 more
Feb 22, 2022
Asthma Trial in Worldwide (Benralizumab, Placebo)
Recruiting
- Asthma
- Benralizumab
- Placebo
-
Los Angeles, California
- +35 more
Feb 1, 2023
Asthma, Severe Eosinophilic Asthma Trial in Worldwide (Symbicort®, Fasenra®, Ventolin®)
Active, not recruiting
- Asthma
- Severe Eosinophilic Asthma
- Symbicort®
- +2 more
-
Brest Cedex, France
- +22 more
Aug 24, 2022
Dysfunctional Breathing in Asthma Trial in Denmark (Breathing Exercises, Usual care)
Active, not recruiting
- Dysfunctional Breathing in Asthma
- Breathing Exercises
- Usual care
-
Silkeborg, Central Denmark Region, Denmark
- +7 more
Aug 24, 2022
3TR Asthma Biologics Cohort (ABC) Study
Recruiting
- Severe Asthma
-
Copenhagen, Denmark
- +1 more
Nov 6, 2023
Moderate Asthma Trial (Long-Acting Beta Agonist)
Not yet recruiting
- Moderate Asthma
- Long-Acting Beta Agonist
- (no location specified)
Feb 24, 2023
Severe Prednisone Dependent Eosinophilic Asthma Trial in Hamilton (Benralizumab, Placebo)
Recruiting
- Severe Prednisone Dependent Eosinophilic Asthma
- Benralizumab
- Placebo
-
Hamilton, Ontario, CanadaFirestone Institute for Respiratory Health, Research - St. Josep
Sep 6, 2021
Asthma, Telemedicine, Adherence, Treatment Trial (The mobile application ESTOI for Asthmatic patients)
Not yet recruiting
- Asthma
- +4 more
- The mobile application ESTOI for Asthmatic patients
- (no location specified)
Nov 5, 2023
Asthma Exacerbation, Physiological Measurements and
Recruiting
- Asthma
-
Raleigh, North CarolinaUNC Children's Raleigh Clinic
Apr 6, 2022
Asthma Trial in Worldwide (Tezepelumab, Placebo)
Recruiting
- Asthma
- Tezepelumab
- Placebo
-
Montgomery, Alabama
- +38 more
Aug 30, 2023
Asthma Trial in Worldwide (Benralizumab (Medi-563), Placebo)
Completed
- Asthma
- Benralizumab (Medi-563)
- Placebo
-
Birmingham, Alabama
- +212 more
Oct 20, 2021
Asthma in Children Trial in Rochester (Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER), Enhanced
Not yet recruiting
- Asthma in Children
- Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER)
- Enhanced Care (EC)
-
Rochester, New YorkUniversity of Rochester Medical Center
May 2, 2023
Malignancy in Severe Asthma Patients Receiving Benralizumab and
Recruiting
- Asthma
- Neoplasms
-
Stockholm, Sweden
- +1 more
Aug 8, 2022
Asthma Trial in Marseille, Montpellier (48 weeks of Benralizumab, Computed tomography)
Active, not recruiting
- Asthma
- 48 weeks of Benralizumab
- Computed tomography
-
Marseille, France
- +1 more
Sep 8, 2022
Mepolizumab and Physical Activity in Severe Asthma
Not yet recruiting
- Asthma
- Asthma; Eosinophilic
- (no location specified)
May 31, 2022
Using Exercise-testing to Explore Patient Differences in Severe
Not yet recruiting
- Asthma
- cardiopulmonary exercise stress test (CPEST)
-
Belfast, Northern Ireland, United KingdomQueen's University Belfast
Feb 16, 2023